<p>(A) Proportion of patients with ≥1 point reduction in PFS (primary endpoint). (B) Improvement of mean PFS total score in FCM- vs. placebo-treated patients throughout the study (Mean differences ± SD vs. baseline: Day 7: −1.2±1.8 vs. −0.8±1.5 points; Day 28: −1.8±2.1 vs. 1.2±2.0 points; Day 56: −2.2±2.1 vs. −1.4±2.0 points). P-values given for intergroup differences. (C) Mean change (Δ) in PFS total score and subscale scores from baseline to Day 56. *P≤0.01 for all scales. (D) Mean change (Δ) in self-rated alertness, contentment and calmness (computer-based VAS scales). *P<0.05; †P = 0.055 vs. placebo.</p
BACKGROUND: The true benefit of iron supplementation for nonanemic menstruating women with fatigue i...
Compared with placebo for adults with RLS, 1000 mg of intravenous iron, usually divided into multipl...
Aim: Improving functional capacity is a key goal in heart failure (HF). This pooled analysis of FAIR...
BACKGROUND: Unexplained fatigue is often left untreated or treated with antidepressants. This random...
BACKGROUND: Unexplained fatigue is often left untreated or treated with antidepressants. This random...
<div><p>Background</p><p>Unexplained fatigue is often left untreated or treated with antidepressants...
Unexplained fatigue is often left untreated or treated with antidepressants. This randomized, placeb...
Unexplained fatigue is often left untreated or treated with antidepressants. This randomized, placeb...
BACKGROUND Unexplained fatigue is often left untreated or treated with antidepressants. This random...
OBJECTIVE: To determine the subjective response to iron therapy in non-anaemic women with unexplaine...
Aim: To determine the impact of iron therapy on the quality of life of non-anaemic iron-deficient w...
Aim: To determine the impact of iron therapy on the quality of life of non-anaemic iron-deficient w...
Background: Unexplained fatigue is often left untreated or treated with antidepressants. This random...
Aim Intravenous ferric carboxymaltose (FCM) has been shown to improve overall quality of life in iro...
Aim Intravenous ferric carboxymaltose (FCM) has been shown to improve overall quality of life in iro...
BACKGROUND: The true benefit of iron supplementation for nonanemic menstruating women with fatigue i...
Compared with placebo for adults with RLS, 1000 mg of intravenous iron, usually divided into multipl...
Aim: Improving functional capacity is a key goal in heart failure (HF). This pooled analysis of FAIR...
BACKGROUND: Unexplained fatigue is often left untreated or treated with antidepressants. This random...
BACKGROUND: Unexplained fatigue is often left untreated or treated with antidepressants. This random...
<div><p>Background</p><p>Unexplained fatigue is often left untreated or treated with antidepressants...
Unexplained fatigue is often left untreated or treated with antidepressants. This randomized, placeb...
Unexplained fatigue is often left untreated or treated with antidepressants. This randomized, placeb...
BACKGROUND Unexplained fatigue is often left untreated or treated with antidepressants. This random...
OBJECTIVE: To determine the subjective response to iron therapy in non-anaemic women with unexplaine...
Aim: To determine the impact of iron therapy on the quality of life of non-anaemic iron-deficient w...
Aim: To determine the impact of iron therapy on the quality of life of non-anaemic iron-deficient w...
Background: Unexplained fatigue is often left untreated or treated with antidepressants. This random...
Aim Intravenous ferric carboxymaltose (FCM) has been shown to improve overall quality of life in iro...
Aim Intravenous ferric carboxymaltose (FCM) has been shown to improve overall quality of life in iro...
BACKGROUND: The true benefit of iron supplementation for nonanemic menstruating women with fatigue i...
Compared with placebo for adults with RLS, 1000 mg of intravenous iron, usually divided into multipl...
Aim: Improving functional capacity is a key goal in heart failure (HF). This pooled analysis of FAIR...